SARAH BARNARD: Open Payments
NPI 1700160447 · NEW TAZEWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 17 payments from 8 companies in 2025. Trend: 2023 $406 · 2024 $379 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $186 |
| ABBVIE INC. | 3 | $80 |
| PFIZER INC. | 1 | $26 |
| Lundbeck LLC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: VRAYLAR, Ozempic, ELIQUIS, REXULTI, XIFAXAN, VOQUEZNA, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
